VivArt-X

The company develops a synthetic, degradable biomaterial designed to facilitate cell engraftment for personalized breast tissue reconstruction and regeneration. Its primary product serves women who have undergone breast tissue removal following a breast cancer diagnosis. The technology aims to provide surgeons with a predictable method to restore breast tissue and improve long-term recovery outcomes for postoperative patients.